stars 1 stars 2 stars 3

Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action. MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.

Website http://www.mesentech.com
Revenue $5 million
Employees 9 (4 on RocketReach)
Founded 2018
Address 2222 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, CA
Phone +1 778-231-2500
Technologies
Industry Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Care, Medical, Therapeutics
Competitors Twilio, RingCentral, Vonage, Infobip, Sinch, Telesign, Telnyx, ZENVIA, Plivo, ClickSend +37 more (view full list)
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies

Mesentech Questions

The Mesentech annual revenue was $5 million in 2026.

Gang Chen is the Director of Medicinal Chemistry of Mesentech.

4 people are employed at Mesentech.

Mesentech is based in Vancouver, British Columbia.

The NAICS codes for Mesentech are [32, 32541, 325, 3254].

The SIC codes for Mesentech are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users